(NYSE: MCK) Mckesson's forecast annual revenue growth rate of 10.32% is forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.91%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.07%.
Mckesson's revenue in 2025 is $344,583,000,000.On average, 7 Wall Street analysts forecast MCK's revenue for 2026 to be $50,077,250,345,551, with the lowest MCK revenue forecast at $48,395,131,006,253, and the highest MCK revenue forecast at $51,294,606,845,563. On average, 6 Wall Street analysts forecast MCK's revenue for 2027 to be $53,671,465,430,635, with the lowest MCK revenue forecast at $51,616,319,652,755, and the highest MCK revenue forecast at $55,013,228,411,047.
In 2028, MCK is forecast to generate $58,874,559,120,882 in revenue, with the lowest revenue forecast at $58,874,559,120,882 and the highest revenue forecast at $58,874,559,120,882.